Preclinical imaging platform - Centre Georges François Leclerc

About

The preclinical imaging platform is located in the heart of the national anticancer center Georges François Leclerc in Dijon. This center already had a great experience of clinical research (phase 1/2).
The preclinical imaging platform scientific team (composed of a radiopharmacist, a pharmaco-physiologist, and a radiophysician) works in close relationships with the clinics (Oncologists, nuclear medicine MDs), offering thus a full-range translational expertise preclinical to clinical.
The preclinical imaging platform enables a full approach of pharmaco-imaging, from chemistry to in vivo imaging, in a totally dedicated environment. The preclinical imaging platform offers customized services including radiolabeling, animal models development (oncology and cardiovascular diseases) and in vivo 3D imaging (Bioscan NanoSPECT®-CT / BioPET®-CT / MRS 1500TM MR solutions).

In addition, the preclinical imaging platform possess strong local partnerships:
* It belongs to the Pharm'Image consortium, a public-private partnership focused on pharmaco-imaging
* It hosts IMAPPI project which develops of a preclinical PET-MRI prototype with the participation of Bioscan subsidiary: Bioscan Molecular Imaging France (BMIF)
* More recently, the platform gathered its skills with a local company: NVH Medicinal, specialized in Engineering and biomanufacturing to offer grouped services focused on biomolecule development

Keywords

cancerologie, centre de lutte contre le cancer, soins, medecine personnalisee, recherche, enseignement

Amenities

No amenities listed yet

Upcoming Events

No upcoming events scheduled

Frequently Asked Questions

No reviews yet. Be the first to review!

Social Links

Photo Gallery

No photos available

Contact Information

Business Info

Location

Business Hours

Business hours not available